CellWell record HH-217552
Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology
Xian-Pei Heng; Liu-Qing Yang; Qi-Wei Chen; Lin-Xi Jin; Yu-Wan Li; Yi Ruan; Zhuang Han; Shu-Hong Yao; Xin-Miao Hong; Zhi-Ta Wang; Liang Li; Wei-Dong He
2026
In plain language
Each 1-unit increase in HOMA-IR was associated with 59.9% higher odds of concurrent MASLD and type 2 diabetes versus neither condition alone.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-217552
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.